FDA Drug Application (021231) for ZOMIG-ZMT by ASTRAZENECA

Back to FDA Applications sponsored by ASTRAZENECA

Application Number021231
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZOMIG-ZMT
Active IngredientZOLMITRIPTAN



Back to FDA Applications sponsored by ASTRAZENECA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.